Diamyd Medical AB (publ)

OM:DMYD B Stock Report

Market Cap: SEK 975.3m

Diamyd Medical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DMYD B?
Owner TypeNumber of SharesOwnership Percentage
Private Companies906,2500.684%
Individual Insiders17,024,96812.9%
Institutions18,671,95414.1%
General Public95,854,05172.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 27.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.03%
Avanza Fonder AB
11,954,656SEK 88.0m0%0.11%
6.55%
Bertil Lindkvist
8,680,000SEK 63.9m0%no data
4.33%
Nordnet AB (publ), Asset Management Arm
5,733,757SEK 42.2m0%0.77%
2.97%
Anders Essen-Möller
3,932,833SEK 29.0m0%no data
1.03%
Maria-Teresa Essen-Möller
1,363,998SEK 10.0m0%no data
0.68%
Konstruktions o Försäljningsaktiebolaget KFAB
906,250SEK 6.7m0%no data
0.68%
Swedbank Robur Fonder AB
899,969SEK 6.6m0%no data
0.51%
Martin Moller
678,436SEK 5.0m0%no data
0.49%
Jon Essen-Moller
645,247SEK 4.8m0%no data
0.46%
Erika Hillborg
603,000SEK 4.4m0%no data
0.44%
My Essenshaw
581,002SEK 4.3m0%no data
0.21%
Ulf Hannelius
282,955SEK 2.1m0%no data
0.11%
Anna Styrud
142,499SEK 1.0m0%no data
0.044%
Erik Nerpin
58,731SEK 432.5k0%no data
0.03%
BlackRock, Inc.
39,991SEK 294.4k-43.2%no data
0.025%
Elite Fund Management Ltd
33,000SEK 242.9k0%0.3%
0.013%
Mark Atkinson
16,750SEK 123.4k0%no data
0.0094%
Martina Widman
12,500SEK 92.1k0%no data
0.008%
FCG Fonder AB
10,581SEK 77.9k0%no data
0.0076%
Karin Hehenberger
10,000SEK 73.6k0%no data
0.0072%
Christoph Nowak
9,507SEK 70.0k0%no data
0.003%
Eva Karlstrom
4,000SEK 29.5k0%no data
0.0019%
Maja Johansson
2,500SEK 18.4k0%no data
0.00075%
Torbjörn Bäckström
1,000SEK 7.3k0%no data
0.00001%
Karin Rosen
10SEK 97.50%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/05 06:06
End of Day Share Price 2025/05/05 00:00
Earnings2025/02/28
Annual Earnings2024/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Diamyd Medical AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ludvig SvenssonCarnegie Commissioned Research
Ludvig SvenssonPenser Access